Anavex Life Sciences Corp (AVXL)

[ChrisMissing]

Way too low George. The bar has been set already by Biogen at I believe is $26K per year. I m sure for the first few years we will be in the same ballpark, maybe slightly higher since our product actually works. We have 10 years of R & D to recover. It will be whatever insurance will bear. You will not see lower prices until the drug is used at lower levels for a preventative treatment like Lipitor. 1M patients x $26k=$26B minus partner cut and manufacturing.